Characteristics of Adult T-Cell Leukemia/Lymphoma Patients with Long Survival: Prognostic Significance of Skin Lesions and Possible Beneficial Role of Valproic Acid

Table 4

Duration of valproic acid (VA) treatment before and after Adult T-cell Leukemia/Lymphoma (ATL) in patients diagnosed between 1st January 1983 and 31st March 2013 presenting with a survival superior to 10 years (long survival) in Martinique.

Patient	VA before ATL onset (years)	VA after ATL onset (years)	Total VA treatment duration (years)
1	20	17	37
2	0	8	8
3	0	13	13
4	0	8	8
5	15	12	27